Tag: Alzheimer’s disease

Cleveland Clinic-led Study Identifies How COVID-19 Linked to Alzheimer’s Disease-like Cognitive Impairment

Researchers used artificial intelligence to uncover association between COVID-19 and brain changes

FDA Approves First New Alzheimer’s Drug in Nearly 20 Years

Cleveland Clinic Lou Ruvo Center for Brain Health Receives NIH and ADDF Grants, Totaling $4.6 Million to Study FDA-Approved Cancer Drug Lenalidomide in Alzheimer’s Disease

Dual studies aim to determine if the repurposed drug safely and effectively reduces inflammatory and disease-associated biomarkers, and improves cognition in early-stage Alzheimer’s disease

National Institute on Aging Awards $3.3 Million to Cleveland Clinic Lou Ruvo Center for Brain Health to Establish Nevada Exploratory Alzheimer’s Disease Research Center

New center is part of the first cohort of centers nationally to receive this new NIH funding and is the first and only in Nevada

The Women’s Alzheimer’s Movement Prevention Center at Cleveland Clinic Launches

New clinic is the first in the nation specific to women for Alzheimer’s disease prevention and is now taking appointments at 833.WOMEN.AD

Cleveland Clinic Releases Fourth Installment of Annual Alzheimer’s Disease Drug Development Pipeline Report

Despite several high profile failures, Alzheimer’s drug development continues with a diverse pipeline beyond amyloid

Marwan Sabbagh, M.D., Named New Director of Cleveland Clinic Lou Ruvo Center for Brain Health

Distinguished clinician, researcher and author brings more than 27 years of expertise in Alzheimer’s disease to lead one of the largest memory disorders group in the country